270 related articles for article (PubMed ID: 20404614)
1. Radioembolization (yttrium-90 microspheres) for primary and metastatic hepatic malignancies.
Kennedy AS; Salem R
Cancer J; 2010; 16(2):163-75. PubMed ID: 20404614
[TBL] [Abstract][Full Text] [Related]
2. 90Y Radioembolization for metastatic neuroendocrine liver tumors: preliminary results from a multi-institutional experience.
Rhee TK; Lewandowski RJ; Liu DM; Mulcahy MF; Takahashi G; Hansen PD; Benson AB; Kennedy AS; Omary RA; Salem R
Ann Surg; 2008 Jun; 247(6):1029-35. PubMed ID: 18520231
[TBL] [Abstract][Full Text] [Related]
3. Selective internal radiation therapy: 90Y (yttrium) labeled microspheres for liver malignancies (primary and metastatic).
Uthappa MC; Ravikumar R; Gupta A
Indian J Cancer; 2011; 48(1):18-23. PubMed ID: 21330750
[TBL] [Abstract][Full Text] [Related]
4. State of the art: radiolabeled microspheres treatment for liver malignancies.
Deleporte A; Flamen P; Hendlisz A
Expert Opin Pharmacother; 2010 Mar; 11(4):579-86. PubMed ID: 20163269
[TBL] [Abstract][Full Text] [Related]
5. Radioembolization in patients with hepatic metastases from breast cancer.
Jakobs TF; Hoffmann RT; Fischer T; Stemmler HJ; Tatsch K; La Fougere C; Murthy R; Reiser MF; Helmberger TK
J Vasc Interv Radiol; 2008 May; 19(5):683-90. PubMed ID: 18440456
[TBL] [Abstract][Full Text] [Related]
6. Hepatic yttrium-90 radioembolization of chemotherapy-refractory colorectal cancer liver metastases.
Jakobs TF; Hoffmann RT; Dehm K; Trumm C; Stemmler HJ; Tatsch K; La Fougere C; Murthy R; Helmberger TK; Reiser MF
J Vasc Interv Radiol; 2008 Aug; 19(8):1187-95. PubMed ID: 18656012
[TBL] [Abstract][Full Text] [Related]
7. Hepatic radioembolization with Yttrium-90 glass microspheres for treatment of primary liver cancer.
Cao X; He N; Sun J; Tan J; Zhang C; Yang J; Lu T; Li J
Chin Med J (Engl); 1999 May; 112(5):430-2. PubMed ID: 11593513
[TBL] [Abstract][Full Text] [Related]
8. Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients.
Kennedy AS; Dezarn WA; McNeillie P; Coldwell D; Nutting C; Carter D; Murthy R; Rose S; Warner RR; Liu D; Palmedo H; Overton C; Jones B; Salem R
Am J Clin Oncol; 2008 Jun; 31(3):271-9. PubMed ID: 18525307
[TBL] [Abstract][Full Text] [Related]
9. Radioembolization in the treatment of unresectable liver tumors: experience across a range of primary cancers.
Coldwell D; Sangro B; Salem R; Wasan H; Kennedy A
Am J Clin Oncol; 2012 Apr; 35(2):167-77. PubMed ID: 21127414
[TBL] [Abstract][Full Text] [Related]
10. Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium.
Kennedy A; Nag S; Salem R; Murthy R; McEwan AJ; Nutting C; Benson A; Espat J; Bilbao JI; Sharma RA; Thomas JP; Coldwell D
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):13-23. PubMed ID: 17448867
[TBL] [Abstract][Full Text] [Related]
11. Radioembolization with yttrium-90 microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies: part 3: comprehensive literature review and future direction.
Salem R; Thurston KG
J Vasc Interv Radiol; 2006 Oct; 17(10):1571-93. PubMed ID: 17056999
[TBL] [Abstract][Full Text] [Related]
12. Radioembolization with 90yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 2: special topics.
Salem R; Thurston KG
J Vasc Interv Radiol; 2006 Sep; 17(9):1425-39. PubMed ID: 16990462
[TBL] [Abstract][Full Text] [Related]
13. Radioembolization versus standard care of hepatic metastases: comparative retrospective cohort study of survival outcomes and adverse events in salvage patients.
Bester L; Meteling B; Pocock N; Pavlakis N; Chua TC; Saxena A; Morris DL
J Vasc Interv Radiol; 2012 Jan; 23(1):96-105. PubMed ID: 22079516
[TBL] [Abstract][Full Text] [Related]
14. 90Y radioembolization of metastatic breast cancer to the liver: toxicity, imaging response, survival.
Bangash AK; Atassi B; Kaklamani V; Rhee TK; Yu M; Lewandowski RJ; Sato KT; Ryu RK; Gates VL; Newman S; Mandal R; Gradishar W; Omary RA; Salem R
J Vasc Interv Radiol; 2007 May; 18(5):621-8. PubMed ID: 17494843
[TBL] [Abstract][Full Text] [Related]
15. Arterial therapies of non-colorectal cancer metastases to the liver (from chemoembolization to radioembolization).
Hoffmann RT; Paprottka P; Jakobs TF; Trumm CG; Reiser MF
Abdom Imaging; 2011 Dec; 36(6):671-6. PubMed ID: 21584635
[TBL] [Abstract][Full Text] [Related]
16. Selective Internal Radiation Therapy (SIRT) for liver metastases secondary to colorectal adenocarcinoma.
Welsh JS; Kennedy AS; Thomadsen B
Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S62-73. PubMed ID: 16979443
[TBL] [Abstract][Full Text] [Related]
17. Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres.
Mulcahy MF; Lewandowski RJ; Ibrahim SM; Sato KT; Ryu RK; Atassi B; Newman S; Talamonti M; Omary RA; Benson A; Salem R
Cancer; 2009 May; 115(9):1849-58. PubMed ID: 19267416
[TBL] [Abstract][Full Text] [Related]
18. Comments on "Hepatic radioembolization with yttrium-90 glass microspheres for treatment of primary liver cancer" by Cao et al, Chin Med J 1999; 112: 430-432.
Ho S; Lau WY; Leung WT
Chin Med J (Engl); 2001 Apr; 114(4):433-4. PubMed ID: 11780473
[No Abstract] [Full Text] [Related]
19. Radioembolization of symptomatic, unresectable neuroendocrine hepatic metastases using yttrium-90 microspheres.
Paprottka PM; Hoffmann RT; Haug A; Sommer WH; Raessler F; Trumm CG; Schmidt GP; Ashoori N; Reiser MF; Jakobs TF
Cardiovasc Intervent Radiol; 2012 Apr; 35(2):334-42. PubMed ID: 21847708
[TBL] [Abstract][Full Text] [Related]
20. Radioembolization with yttrium microspheres for neuroendocrine tumour liver metastases.
Cao CQ; Yan TD; Bester L; Liauw W; Morris DL
Br J Surg; 2010 Apr; 97(4):537-43. PubMed ID: 20205229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
